Nevertheless, our findings in this study would provide VDAC1 as a potential target for ALI and also VDAC1 inhibitor (+)3C‐20 as a valuable drug candidate for the treatment of ALI. The gene discussed is VDAC1; the disease is acute respiratory distress syndrome.